Regulation of pharmaceutical innovation: the 1962 amendments
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
American Enterprise Inst. for Public Policy Research
1974
|
| Schriftenreihe: | American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies
15 |
| Schlagworte: | |
| Beschreibung: | 118 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007382085 | ||
| 003 | DE-604 | ||
| 005 | 19950302 | ||
| 007 | t | ||
| 008 | 930421s1974 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)1037888 | ||
| 035 | |a (DE-599)BVBBV007382085 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-945 | ||
| 050 | 0 | |a KF3885.Z9 | |
| 082 | 0 | |a 344/.73/042 | |
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 100 | 1 | |a Peltzman, Sam |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Regulation of pharmaceutical innovation |b the 1962 amendments |c Sam Peltzman |
| 264 | 1 | |a Washington, DC |b American Enterprise Inst. for Public Policy Research |c 1974 | |
| 300 | |a 118 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies |v 15 | |
| 650 | 4 | |a Industrie pharmaceutique - États-Unis | |
| 650 | 4 | |a Médicaments - Droit - États-Unis | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Drugs |x Law and legislation |z United States | |
| 650 | 4 | |a Economics |z United States | |
| 650 | 4 | |a Pharmaceutical Preparations |x standards |z United States | |
| 650 | 0 | 7 | |a Produktinnovation |0 (DE-588)4047346-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazie |0 (DE-588)4045705-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Produktinnovation |0 (DE-588)4047346-6 |D s |
| 689 | 0 | 1 | |a Pharmazie |0 (DE-588)4045705-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 830 | 0 | |a American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies |v 15 |w (DE-604)BV002790003 |9 15 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004769246 | ||
Datensatz im Suchindex
| _version_ | 1804121634699739136 |
|---|---|
| any_adam_object | |
| author | Peltzman, Sam |
| author_facet | Peltzman, Sam |
| author_role | aut |
| author_sort | Peltzman, Sam |
| author_variant | s p sp |
| building | Verbundindex |
| bvnumber | BV007382085 |
| callnumber-first | K - Law |
| callnumber-label | KF3885 |
| callnumber-raw | KF3885.Z9 |
| callnumber-search | KF3885.Z9 |
| callnumber-sort | KF 43885 Z9 |
| callnumber-subject | KF - United States |
| classification_rvk | QX 700 |
| ctrlnum | (OCoLC)1037888 (DE-599)BVBBV007382085 |
| dewey-full | 344/.73/042 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 344 - Labor, social, education & cultural law |
| dewey-raw | 344/.73/042 |
| dewey-search | 344/.73/042 |
| dewey-sort | 3344 273 242 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01720nam a2200469 cb4500</leader><controlfield tag="001">BV007382085</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19950302 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1974 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1037888</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007382085</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-945</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">KF3885.Z9</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">344/.73/042</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Peltzman, Sam</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Regulation of pharmaceutical innovation</subfield><subfield code="b">the 1962 amendments</subfield><subfield code="c">Sam Peltzman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">American Enterprise Inst. for Public Policy Research</subfield><subfield code="c">1974</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">118 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies</subfield><subfield code="v">15</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Droit - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Produktinnovation</subfield><subfield code="0">(DE-588)4047346-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazie</subfield><subfield code="0">(DE-588)4045705-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Produktinnovation</subfield><subfield code="0">(DE-588)4047346-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazie</subfield><subfield code="0">(DE-588)4045705-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies</subfield><subfield code="v">15</subfield><subfield code="w">(DE-604)BV002790003</subfield><subfield code="9">15</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004769246</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV007382085 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:01:06Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004769246 |
| oclc_num | 1037888 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-945 |
| owner_facet | DE-355 DE-BY-UBR DE-945 |
| physical | 118 S. graph. Darst. |
| publishDate | 1974 |
| publishDateSearch | 1974 |
| publishDateSort | 1974 |
| publisher | American Enterprise Inst. for Public Policy Research |
| record_format | marc |
| series | American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies |
| series2 | American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies |
| spelling | Peltzman, Sam Verfasser aut Regulation of pharmaceutical innovation the 1962 amendments Sam Peltzman Washington, DC American Enterprise Inst. for Public Policy Research 1974 118 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies 15 Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Economics United States Pharmaceutical Preparations standards United States Produktinnovation (DE-588)4047346-6 gnd rswk-swf Pharmazie (DE-588)4045705-9 gnd rswk-swf USA Produktinnovation (DE-588)4047346-6 s Pharmazie (DE-588)4045705-9 s DE-604 American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies 15 (DE-604)BV002790003 15 |
| spellingShingle | Peltzman, Sam Regulation of pharmaceutical innovation the 1962 amendments American Enterprise Inst. for Public Policy Research <Washington, DC>: Evaluative studies Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Economics United States Pharmaceutical Preparations standards United States Produktinnovation (DE-588)4047346-6 gnd Pharmazie (DE-588)4045705-9 gnd |
| subject_GND | (DE-588)4047346-6 (DE-588)4045705-9 |
| title | Regulation of pharmaceutical innovation the 1962 amendments |
| title_auth | Regulation of pharmaceutical innovation the 1962 amendments |
| title_exact_search | Regulation of pharmaceutical innovation the 1962 amendments |
| title_full | Regulation of pharmaceutical innovation the 1962 amendments Sam Peltzman |
| title_fullStr | Regulation of pharmaceutical innovation the 1962 amendments Sam Peltzman |
| title_full_unstemmed | Regulation of pharmaceutical innovation the 1962 amendments Sam Peltzman |
| title_short | Regulation of pharmaceutical innovation |
| title_sort | regulation of pharmaceutical innovation the 1962 amendments |
| title_sub | the 1962 amendments |
| topic | Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Economics United States Pharmaceutical Preparations standards United States Produktinnovation (DE-588)4047346-6 gnd Pharmazie (DE-588)4045705-9 gnd |
| topic_facet | Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Recht Wirtschaft Drug Industry United States Drugs Law and legislation United States Economics United States Pharmaceutical Preparations standards United States Produktinnovation Pharmazie USA |
| volume_link | (DE-604)BV002790003 |
| work_keys_str_mv | AT peltzmansam regulationofpharmaceuticalinnovationthe1962amendments |